申请人:Iizuka Masato
公开号:US20130217878A1
公开(公告)日:2013-08-22
(Aza)indolizine derivatives represented by Formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, salts thereof or the like. In Formula (I), 0 to 2 of X
1
, X
2
, X
3
and X
4
are a nitrogen atom and the others are CR
1
; one of T
1
and T
2
represents cyano and the other represents a group represented by Formula (A), with the proviso that when T
1
is cyano, at least one of X
1
to X
4
is a nitrogen atom; R
1
independently represents a hydrogen atom, a halogen atom, a hydroxy group, C
1-6
alkyl, C
1-6
alkoxy or the like; ring U represents a benzene ring or the like; m represents integral number from 0 to 2; R
2
independently represents a fluorine atom, a hydroxy group or the like.
公式(I)表示的Aza吲哚啉衍生物具有黄嘌呤氧化酶抑制活性,并可用作预防或治疗与血清尿酸水平异常相关的疾病的药物,其前药,盐或类似物。在公式(I)中,X1,X2,X3和X4中的0至2个是氮原子,其余为CR1;T1和T2中的一个表示氰基,另一个表示由公式(A)表示的基团,但是当T1是氰基时,X1至X4中至少有一个是氮原子;R1独立地表示氢原子,卤素原子,羟基,C1-6烷基,C1-6烷氧基或类似物;环U表示苯环或类似物;m表示从0到2的整数;R2独立地表示氟原子,羟基或类似物。